Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jun;33(6):1562–1566. doi: 10.1128/jcm.33.6.1562-1566.1995

Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.

M Holodniy 1, L Mole 1, B Yen-Lieberman 1, D Margolis 1, C Starkey 1, R Carroll 1, T Spahlinger 1, J Todd 1, J B Jackson 1
PMCID: PMC228216  PMID: 7650187

Abstract

This study compared the levels of human immunodeficiency virus (HIV) virion RNA in plasma from whole blood collected in VACUTAINER CPT (cell preparation tube), VACUTAINER PPT (plasma preparation tube), VACUTAINER SST (serum separation tube), and standard VACUTAINER tubes with sodium heparin, acid citrate dextrose, sodium citrate, and potassium EDTA used as anticoagulants. Quantitative plasma HIV RNA levels were measured by branched-DNA signal amplification. Blood from all tubes was either processed within 1 to 3 h after collection or stored at room temperature or at 4 degrees C for analysis at 6 to 8 and 30 h postdraw. Immediately separated plasma from sodium citrate CPT tubes held at 4 degrees C maintained better stability of HIV RNA equivalents than whole blood held at room temperature or 4 degrees C. The highest number of HIV RNA equivalents was seen with EDTA VACUTAINER tubes. HIV RNA equivalents in all types of plasma were significantly higher than in SST tubes. Although a decline in HIV RNA equivalents was seen in all collection devices after 30 h, a significantly greater decline in plasma HIV RNA equivalents occurred in acid citrate dextrose VACUTAINER tubes than in citrate CPT, PPT, and standard EDTA VACUTAINER tubes. In order to minimize the variability of quantitative HIV RNA test results, our data suggest that samples collected for a particular assay should be processed at the same time postdraw using a particular tube type throughout a given study.

Full Text

The Full Text of this article is available as a PDF (208.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coombs R. W., Henrard D. R., Mehaffey W. F., Gibson J., Eggert E., Quinn T. C., Phillips J. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol. 1993 Aug;31(8):1980–1986. doi: 10.1128/jcm.31.8.1980-1986.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Holodniy M., Katzenstein D. A., Israelski D. M., Merigan T. C. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J Clin Invest. 1991 Nov;88(5):1755–1759. doi: 10.1172/JCI115494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Holodniy M., Kim S., Katzenstein D., Konrad M., Groves E., Merigan T. C. Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol. 1991 Apr;29(4):676–679. doi: 10.1128/jcm.29.4.676-679.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holodniy M., Mole L., Winters M., Merigan T. C. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr. 1994 Apr;7(4):363–368. [PubMed] [Google Scholar]
  5. Lee T. H., Stromberg R. R., Henrard D., Busch M. P. Effect of platelet-associated virus on assays of HIV-1 in plasma. Science. 1993 Dec 3;262(5139):1585–1586. doi: 10.1126/science.8248811. [DOI] [PubMed] [Google Scholar]
  6. Mole L., Margolis D., Carroll R., Todd J., Holodniy M. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes. J Clin Microbiol. 1994 Sep;32(9):2212–2215. doi: 10.1128/jcm.32.9.2212-2215.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Moudgil T., Daar E. S. Infectious decay of human immunodeficiency virus type 1 in plasma. J Infect Dis. 1993 Jan;167(1):210–212. doi: 10.1093/infdis/167.1.210. [DOI] [PubMed] [Google Scholar]
  8. O'Shea S., Rostron T., Mullen J. E., Banatvala J. E. Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood. J Clin Pathol. 1994 Feb;47(2):152–154. doi: 10.1136/jcp.47.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. doi: 10.1126/science.8096089. [DOI] [PubMed] [Google Scholar]
  10. Urdea M. S., Wilber J. C., Yeghiazarian T., Todd J. A., Kern D. G., Fong S. J., Besemer D., Hoo B., Sheridan P. J., Kokka R. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS. 1993 Nov;7 (Suppl 2):S11–S14. doi: 10.1097/00002030-199311002-00004. [DOI] [PubMed] [Google Scholar]
  11. Vernazza P. L., Eron J. J., Fiscus S. A. Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J Infect Dis. 1993 Nov;168(5):1269–1272. doi: 10.1093/infdis/168.5.1269. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES